Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis

Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis

AimsMetabolic associated fatty liver disease (MAFLD) is the most common cause of chronic liver disease and is a major health and economic burden in society. New drugs are urgently needed to treat MAFLD. This systematic review and meta-analysis was conducted to evaluate the efficacy of glucagon-like...

Full description

Bibliographic Details
Main Authors: Yuzhao Dai, He He, Sheyu Li, Lidan Yang, Xia Wang, Zhi Liu, Zhenmei An
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Endocrinology
Subjects:
metabolic associated fatty liver disease
non-alcoholic fatty liver disease (NAFLD)
metabolic syndrome
systematic review
meta-analysis
glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2020.622589/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2020.622589/full

Similar Items